Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Gal3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | mediates | process | 0.95 |
| Microglial Activation | promotes | process | 0.95 |
| TREM2 | interacts_with | protein | 0.90 |
| Huntington'S Disease | implicated_in | disease | 0.90 |
| Alzheimer disease brain parenchyma | associated_with | brain_region | 0.90 |
| tau | co-aggregates_with | protein | 0.90 |
| tau fibrillation | enhances | mechanism | 0.70 |
| NF-κB activation | modulates | pathway | 0.70 |
| tau-Gal3 co-aggregates | causes | mechanism | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Berbamine Hydrochloride | inhibits | drug | 0.95 |
| Lysosomal Damage | activates | process | 0.90 |
| CLEC7A | regulates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning Gal3 in their description or question text
No additional research found